fr   en
Fundraisings
Select a company :
Select an investor :
Choose date:
[<<]      «      3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13      »      [23]
Date Company Amount Investors Planned use / Other
2009-10-30 PDC Biotech (Austria) €4 million MIG Verwaltungs AG (Germany)
Edmond de Rothschild Investment Partners (France)
See details
2009-10-29 Pronota (Belgium) € 1.3 million MP Healthcare Venture Management (USA)
This is a jointly owned subsidiary of Mitsubishi Tanabe Pharma Corporation and its parent company, Mitsubishi Chemical Holdings Corporation in Japan.
See details
2009-10-29 Promethera Biosciences (Belgium) € 5.3 million Vesalius Biocapital (Belgium)
SRIW
Life Science Research Partners
NivelInvest
Capital & Croissance
LRM Oxygen for Growth
Vives
business angels
See details
2009-10-28 Nabriva Therapeutics (Austria) € 15 million ($ 22 million) Nomura Phase 4 Ventures (UK)
HBM Partners (Switzerland)
Wellcome Trust (UK)
GLS Ventures (Germany)
Novartis Venture Fund (Switzerland)
See details
2009-10-23 Biotie Therapies (Finland) up to € 20 million YA Global Master SPV
(fund managed by Yorkville Advisors, LLC - USA)
See details
2009-10-22 Nokad (France) € 1.6 million CapDecisif Management (France)
G1J Ile-de-France (France)
SHAM (France)
See details
2009-10-19 SYGNIS Pharma (Germany) up to € 10 million YA Global Master SPV LTD (YA Global) a fund managed by Yorkville Advisors, LLC located in New Jersey USA See details
2009-10-16 Galapagos (Belgium) €18.2 million International institutional investors See details
2009-10-13 Amarin (UK) $70 million ($66.4 million in cash proceeds and $3.6 million from the conversion of convertible bridge notes) Fountain Healthcare Partners
Sofinnova Ventures
Orbimed Advisors
Longitude Capital
Abingworth
APG Asset Management
Great Point Partners
Tavistock Life Sciences Company
RA Capital
See details
2009-10-12 Crescendo Biologics (UK) £4.5 million Sofinnova Partners (France)
Aitua (UK)
Avlar BioVentures (UK)
Rainbow Seed Fund (UK)
See details
2009-10-07 Diamyd Medical (Sweden) SEK 220 million ( € 21.8 million) existing shareholders See details
2009-10-06 Bicycle Therapeutics (UK)   Atlas Venture (USA-UK)
Novartis Venture Fund (Switzerland)
See details
2009-10-06 Bicycle Therapeutics (UK) seed funding Atlas Venture (UK -USA)
Novartis Venture Fund (Switzerland)
See details
2009-10-05 Covagen (Switzerland) undisclosed amount Novartis Venture Fund (Switzerland)
MP Healthcare Venture Management (USA)
See details
2009-10-05 Covagen (Switzerland) undisclosed Novartis Venture Fund (Switzerland)
MP Healthcare Venture Management (USA)
See details
[<<]      «      3   |   4   |   5   |   6   |   7   |   8   |   9   |   10   |   11   |   12   |   13      »      [23]